A combinatorial therapy for pneumonia in elderly people.
Kanda
Akio
A
Ebihara
Satoru
S
Yasuda
Hiroyasu
H
Takashi
Ohrui
O
Sasaki
Takahiko
T
Sasaki
Hidetada
H
D000203:Activities of Daily Living; D000368:Aged; D000369:Aged, 80 and over; D000547:Amantadine / Q000008:administration & dosage* / Q000009:adverse effects; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016009:Chi-Square Distribution; D017714:Community-Acquired Infections / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D048289:Imidazolidines; D007902:Length of Stay; D008297:Male; D008712:Methicillin / Q000494:pharmacology; D016106:Methicillin Resistance; D010068:Oxacillin / Q000494:pharmacology; D011014:Pneumonia / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology; D013902:Radiography, Thoracic; D013183:Sputum / Q000382:microbiology; D013203:Staphylococcal Infections / Q000517:prevention & control; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D013997:Time Factors; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D000900:Anti-Bacterial Agents; D000959:Antihypertensive Agents; D007093:Imidazoles; D048289:Imidazolidines; D000547:Amantadine; C065166:imidapril; D008712:Methicillin; D010068:Oxacillin